Comparison
Abducens Nerve Neoplasm C1263898 vs 16p13 11 Microduplication Syndrome C4304595
Clinical comparison between Abducens Nerve Neoplasm and 16p13 11 Microduplication Syndrome for differential diagnosis and treatment planning.
Abducens Nerve Neoplasm C1263898
A tumor of the 6th cranial nerve that controls eye movement. Can affect anyone. Treated with surgery or radiation.
16p13 11 Microduplication Syndrome C4304595
A rare genetic condition from duplication of a segment on chromosome 16. Features may include developmental delays and learning differences. Management focuses on supportive care and early intervention.
6 comparison axes
Onset
Abducens Nerve Neoplasm C1263898
Variable
16p13 11 Microduplication Syndrome C4304595
0-null
Onset patterns differ
Severity
Abducens Nerve Neoplasm C1263898
severe
16p13 11 Microduplication Syndrome C4304595
moderate
Different severity levels
Chronic
Abducens Nerve Neoplasm C1263898
Chronic
16p13 11 Microduplication Syndrome C4304595
Chronic
Differing course
Communicable
Abducens Nerve Neoplasm C1263898
No
16p13 11 Microduplication Syndrome C4304595
No
Different transmission
Body System
Abducens Nerve Neoplasm C1263898
neurologic
16p13 11 Microduplication Syndrome C4304595
congenital
Same/different system
Category
Abducens Nerve Neoplasm C1263898
oncology
16p13 11 Microduplication Syndrome C4304595
genetic
Different category
Bottom line
abducens-nerve-neoplasm-C1263898 and 16p13-11-microduplication-syndrome-C4304595 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | Abducens Nerve Neoplasm C1263898 | 16p13 11 Microduplication Syndrome C4304595 | Discriminating power |
|---|---|---|---|
| Eye movement | May cause impaired outward gaze or double vision if the sixth nerve is affected. | Eye-movement palsy is not an established core feature from the supplied description. | High |
| Development | Developmental delay is not described as a defining feature. | May include developmental delay and learning differences. | High |
| Onset pattern | Onset is variable and depends on tumor behavior. | The condition is congenital, although recognition may occur later. | Moderate |
When to favor each condition
Choose Abducens Nerve Neoplasm C1263898 when
New binocular double vision or restricted eye movement
These findings fit a neurologic process involving the abducens nerve better than the genetic description.
Moderate
Imaging suggests a mass near the sixth nerve
A neoplasm is supported by localized tumor evidence rather than a chromosomal finding.
High
Progressive cranial-nerve deficit
Progression may prompt evaluation for tumor, but the cause is not established without assessment.
Moderate
Choose 16p13 11 Microduplication Syndrome C4304595 when
Congenital or early developmental concerns
The supplied syndrome description centers on developmental and learning differences.
Moderate
Confirmed 16p13.11 duplication
A genetic test result can support the syndrome, but clinical correlation remains necessary.
High
Family history or multiple congenital features
These may justify genetic evaluation; they do not prove this specific duplication.
Low
How key tests differ
| Test | Abducens Nerve Neoplasm C1263898 | 16p13 11 Microduplication Syndrome C4304595 | Interpretation |
|---|---|---|---|
| Neuroimaging | May show a lesion involving the abducens nerve or nearby structures. | No specific structural lesion is established by the supplied data. | Imaging helps localize a neurologic lesion but does not diagnose the genetic syndrome. |
| Chromosomal microarray | Not expected to identify the neoplasm. | May detect duplication at 16p13.11 when clinically indicated. | A duplication is a genetic finding requiring specialist interpretation. |
| Eye-movement examination | May show impaired abduction or diplopia. | No characteristic eye-movement result is established here. | Abnormal examination is a finding, not proof of tumor. |
Prognosis comparison
Abducens Nerve Neoplasm C1263898
- Outcome
- Outcome is not established from these data and may depend on tumor extent and treatment response.
- Factors
- Location, growth, neurologic effects, and treatment tolerance.
16p13 11 Microduplication Syndrome C4304595
- Outcome
- Often managed supportively; long-term outcome varies and is not quantified here.
- Factors
- Developmental profile, associated findings, and access to intervention.
Time frame: Both may be chronic, but individual course is uncertain.
No mortality, prevalence, or exact prognosis can be inferred from the supplied material.
Complications comparison
| Complication | Presentation |
|---|---|
| Vision-related effects | Double vision or restricted gaze may occur. Specific visual complications are not established. Impact depends on individual findings and treatment. |
| Treatment burden | Surgery or radiation may be considered. Management is generally supportive and developmental. Exact treatment choices and risks require specialist judgment. |
| Learning needs | Learning effects are not a stated core feature. Learning differences and developmental delay may require support. Needs vary and are not predictable from the label alone. |
Patient education highlights
- HighDifferent conditions
A nerve tumor and a chromosomal duplication have different causes, tests, and care pathways.
- HighUrgent eye symptoms
New double vision, eye-movement loss, headache, or neurologic change needs prompt clinical assessment.
- MediumSupportive care
For the genetic condition, early developmental and educational support may be helpful.